Bailout left atrial appendage occluder for pulmonary vein isolation and electrical cardioversion in patients with atrial fibrillation and left atrial appendage thrombus: a pilot study

[1]  C. Giannattasio,et al.  Prevalence and Rate of Resolution of Left Atrial Thrombus in Patients with Non-Valvular Atrial Fibrillation: A Two-Center Retrospective Real-World Study , 2022, Journal of clinical medicine.

[2]  D. Mark,et al.  Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure , 2021, Circulation.

[3]  C. Morillo,et al.  Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. , 2020, The New England journal of medicine.

[4]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[5]  P. Neužil,et al.  Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.

[6]  G. Nickenig,et al.  Clinical outcomes and thrombus resolution in patients with solid left atrial appendage thrombi: results of a single-center real-world registry , 2020, Clinical Research in Cardiology.

[7]  R. Trohman,et al.  Safety and feasibility of radiofrequency redo pulmonary vein isolation ablation for atrial fibrillation after Amulet implantation and device electrical characteristics , 2020, HeartRhythm case reports.

[8]  Dhanunjaya R. Lakkireddy,et al.  Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review. , 2020, JACC. Clinical electrophysiology.

[9]  C. Karabay,et al.  How to safely occlude left atrial appendage with a thrombus inside? , 2020, Anatolian journal of cardiology.

[10]  A. Natale,et al.  Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices. , 2019, Journal of the American College of Cardiology.

[11]  K. Stein,et al.  Combining left atrial appendage closure and catheter ablation for atrial fibrillation: 2-year outcomes from a multinational registry. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[12]  F. Asch,et al.  Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study , 2019, JACC: Cardiovascular Interventions.

[13]  G. Hindricks,et al.  Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[14]  Pekka Raatikainen,et al.  Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial , 2019, JAMA.

[15]  Sang Hoon Lee,et al.  The incidence of left atrial appendage thrombi on transesophageal echocardiography after pretreatment with apixaban for cardioversion in the real-world practice , 2018, PloS one.

[16]  E. Pokushalov,et al.  Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  X. Freixa,et al.  Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[18]  A. Tzikas.  Left Atrial Appendage Occlusion with Amplatzer Cardiac Plug and Amplatzer Amulet: a Clinical Trials Update. , 2017, Journal of atrial fibrillation.

[19]  S. Kische,et al.  Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.

[20]  A. Banerjee,et al.  Atrial fibrillation: the current epidemic , 2017, Journal of geriatric cardiology : JGC.

[21]  A. Natale,et al.  Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry , 2017, Journal of cardiovascular electrophysiology.

[22]  R. Virmani,et al.  Rationale of cerebral protection devices in left atrial appendage occlusion , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  S. Yoshimura,et al.  Resolving Thrombus in the Left Atrial Appendage by Edoxaban Treatment after Acute Ischemic Stroke: Report of 2 Cases. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[24]  J. Saw,et al.  Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure. , 2015, JACC. Cardiovascular interventions.

[25]  V. Reddy,et al.  Ablation for Atrial Fibrillation Combined With Left Atrial Appendage Closure. , 2015, JACC. Clinical electrophysiology.

[26]  K. Phillips,et al.  Left atrial catheter ablation subsequent to Watchman® left atrial appendage device implantation: a single centre experience. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  P. Noseworthy,et al.  Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients. , 2015, Heart rhythm.

[28]  Hong Jiang,et al.  Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives. , 2015, Journal of thoracic disease.

[29]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[30]  Faisal Rahman,et al.  Global epidemiology of atrial fibrillation , 2014, Nature Reviews Cardiology.

[31]  B. Grubb,et al.  Catheter Ablation and Antiarrhythmic Drug Therapy as First- or Second-Line Therapy in the Management of Atrial Fibrillation: Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[32]  Jamil Mayet,et al.  A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) , 2014, Circulation. Arrhythmia and electrophysiology.

[33]  M. O'Neill,et al.  Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.

[34]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[35]  J. Halperin,et al.  Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. , 2012, European heart journal.

[36]  M. Aikawa,et al.  Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation. , 2011, Journal of cardiology.

[37]  V. Fuster,et al.  ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.

[38]  I. V. Van Gelder,et al.  Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. , 1999, The American journal of cardiology.

[39]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[40]  D. Fatkin,et al.  Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. , 1994, Journal of the American College of Cardiology.

[41]  T. Potpara,et al.  Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[42]  R. Siegel,et al.  Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation. , 2019, The American journal of cardiology.

[43]  M. Rienstra,et al.  Atrial fibrillation , 2016, Nature Reviews Disease Primers.